Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial

• Auteurs principaux: Byung Jin Kim MD, PhD (Auteur), Kwang Soo Cha MD, PhD (Auteur), Wook Hyun Cho MD, PhD (Auteur), Eung Ju Kim MD, PhD (Auteur), Seung-Hyuk Choi MD, PhD (Auteur), Moo Hyun Kim MD, PhD (Auteur), Sang-Hyun Kim MD, PhD (Auteur), Jun-Bean Park MD, PhD (Auteur), Seong-Mi Park MD, PhD (Auteur), Il Suk Sohn MD, PhD (Auteur), Kyu Hyung Ryu MD, PhD (Auteur), In-Ho Chae MD, PhD (Auteur)
• Format: Livre
• Publié: SAGE Publishing, 2023-10-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Introduction This study evaluated the efficacy and safety of a single-pill triple-combination of olmesartan/amlodipine/rosuvastatin (Olme/Amlo/Rosu) in comparison with a single-pill dual-combination of olmesartan/amlodipine (Olme/Amlo) in hypertensive patients with low-to-moderate cardiovascular ris...